Avantor Inc (AVTR)

Nov 6, 2026

Avantor Inc. reported a return to year-over-year revenue growth in the third quarter of 2026, with sales increasing 4.6% to $1.70 billion. This strong performance led the company to raise its 2026 outlook for organic revenue growth, adjusted earnings, and free cash flow. Despite growth in both operating segments, profitability in the larger VWR Distribution & Services segment remained under pressure due to an unfavorable product mix and higher expenses.

Nov 5, 2026

Avantor Inc. has appointed Mikey Santiago as its new chief information officer, tasking him with leading the life sciences supplier's global IT strategy and digital transformation initiatives. Santiago brings over 20 years of technology leadership experience, including expertise in corporate integrations, cybersecurity, and artificial intelligence, gained from previous roles at Danaher Corp. His appointment is expected to help Avantor enhance operational efficiency, improve customer service, and strengthen coordination across its global operations through advanced technology.

Oct 28, 2026

Avantor reported a strong return to organic revenue growth in Q3 2026, with revenue of $1.698 billion, exceeding expectations due to robust performance in its VWR Distribution and Services and Bioscience and MedTech Products (BMP) segments. The company raised its 2026 guidance for organic revenue, adjusted EPS, and free cash flow, reflecting positive momentum in end markets and the effectiveness of its Revival strategic program. Management emphasized strong cash generation and a commitment to reducing the adjusted net leverage ratio to below 3x by year-end.

Oct 28, 2026

Avantor (NYSE:AVTR) reported a 4.6% year-over-year sales increase to $1.6983 billion in the third quarter of 2026, alongside a net income of $203.4 million, a significant improvement from a loss in the prior year. The company provided updated 2026 guidance, forecasting organic revenue growth of 0.75%–1.25%, adjusted earnings per share of $0.81–$0.83, and free cash flow between $525 million and $550 million.

Oct 28, 2026

Avantor (NYSE:AVTR) reported an upbeat Q3 2026, exceeding Wall Street's revenue expectations with a 4.6% year-on-year increase to $1.70 billion. The life sciences company also beat non-GAAP profit estimates with $0.22 per share. Despite these positive results, shares fell 2.5% immediately after the release, though management slightly raised its full-year adjusted EPS guidance.